Brand name drug makers are facing more lawsuits and federal investigations for a practice they’ve been carrying on for years: tweaking formulations for brand name drugs slightly just as their patents are about to expire, making it difficult for pharmacists to automatically substitute generic drugs for the redesigned brand.